Adenovirus-mediated HSV-TK Gene Therapy Using hTERT Promoter in CNE Cells in vitro

被引:0
|
作者
ZHANG Yu1
2.Department of Radiotherapy
机构
基金
中国国家自然科学基金;
关键词
hTERT; HSV-TK; Adenovirus; Nasopharyngeal carcinoma;
D O I
暂无
中图分类号
R739.63 [咽肿瘤];
学科分类号
100214 ;
摘要
Human telomerase reverse transcriptase(hTERT) activity was detected in human nasopharyngeal carci-noma cell(CNE) but not in human normal lung fibroblas t(CCD-11Lu).Recombinant adenoviruses Ad-CMV-TK-enh and Ad-hTERT-TK-enh were constructed and infected into normal fibroblasts and nasopharyngeal carcinoma cells.Ad-CMV-TK-enh with 100 μmol/L of ganciclovir(GCV) caused 87% of CCD-11Lu cells death and 91% of CNE cells death,Ad-hTERT-TK-enh with 100 μmol/L of GCV caused 24% of CCD-11Lu cells death and 79% of CNE cells death.These results indicate that the Ad-hTERT-TK-enh with GCV may be a useful method in suppressing tumor growth in targeted nasopharyngeal carcinoma gene therapy.
引用
收藏
页码:60 / 63
页数:4
相关论文
共 50 条
  • [31] Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk
    Morris, JC
    Wildner, O
    [J]. MOLECULAR THERAPY, 2000, 1 (01) : 56 - 62
  • [32] Assessments for prediction of bystander effect in HSV-tk/GCV gene therapy
    Kenmochi, Hiroaki
    Yamasaki, Tomohiro
    Namba, Hiroki
    [J]. CANCER SCIENCE, 2018, 109 : 252 - 252
  • [33] ASSESSMENTS FOR PREDICTION OF BYSTANDER EFFECT IN HSV-TK/GCV GENE THERAPY
    Kenmochi, H.
    Yamasaki, T.
    Horikawa, M.
    Yamamoto, T.
    Koizumi, S.
    Sameshima, T.
    Namba, H.
    [J]. NEURO-ONCOLOGY, 2018, 20 : 295 - 295
  • [34] Gene therapy with HSV-TK: A promising tool for pancreatic cancer treatment?
    Greco, E
    Fogar, P
    Pedrazzoli, S
    Basso, D
    Navaglia, F
    Mazza, NGS
    Zambon, CF
    Plebani, M
    [J]. CLINICAL CHEMISTRY, 2002, 48 (06) : A180 - A180
  • [35] Adenovirus-mediated Gene Therapy for Allergy
    Ma, Shikun
    Guan, Jian
    [J]. IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2018, 17 (06) : 502 - 516
  • [36] Ovarian Cancer Gene Therapy Using HPV-16 Pseudovirion Carrying the HSV-tk Gene
    Hung, Chien-Fu
    Chiang, An Jen
    Tsai, Hsiao-Hsuan
    Pomper, Martin G.
    Kang, Tae Heung
    Roden, Richard R.
    Wu, T. -C.
    [J]. PLOS ONE, 2012, 7 (07):
  • [37] HSV-tk/GCV gene therapy mediated by EBV-LMPI for EBV-associated cancer
    Yang Lifang
    Tang Min
    Ai Midan
    Cao Ya
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2008, 27 (1)
  • [38] Induction of the suicide HSV-TK gene by activation of the Egr-1 promoter with radioisotopes
    Takahashi, T
    Namiki, Y
    Ohno, T
    [J]. HUMAN GENE THERAPY, 1997, 8 (07) : 827 - 833
  • [39] Adenovirus-mediated suicide gene therapy in an in vitro model of reactive gliosis
    Audouy, S
    Mallet, J
    Privat, A
    Ribotta, MGY
    [J]. GLIA, 1999, 25 (03) : 293 - 303
  • [40] Enhancement of tumor killing using a combination of tumor immunization and HSV-tk suicide gene therapy
    Ramesh, R
    Munshi, A
    Marrogi, AJ
    Freeman, SM
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1999, 80 (03) : 380 - 386